PF-06273340
Sponsors
Pfizer
Conditions
Healthy
Phase 1
A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State
CompletedNCT01706796
Start: 2012-11-30End: 2013-01-31Updated: 2013-01-24
A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)
CompletedNCT01934738
Start: 2013-10-31End: 2014-03-31Updated: 2014-03-11
Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain Endpoints
CompletedNCT02260947
Start: 2014-10-31End: 2014-12-31Updated: 2015-02-04